The relationship between the tissue plasminogen activator Alu I/D polymorphism and venous thromboembolism during pregnancy.
Hooper
W C
WC
Hematologic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. chooper@cdc.gov
El-Jamil
M
M
Dilley
A
A
Philipp
C
C
Ellingsen
D
D
Phillips
D
D
Evatt
B L
BL
D000483:Alleles; D020087:Alu Elements; D044383:Black People / Q000235:genetics; D016022:Case-Control Studies; D005260:Female; D005343:Fibrinolytic Agents / Q000097:blood; D005787:Gene Frequency; D006801:Humans; D011110:Polymorphism, Genetic; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000097:blood* / Q000453:epidemiology; D013923:Thromboembolism / Q000097:blood / Q000453:epidemiology / Q000235:genetics; D010959:Tissue Plasminogen Activator / Q000097:blood / Q000235:genetics*; D020246:Venous Thrombosis / Q000097:blood* / Q000453:epidemiology / Q000235:genetics; D044465:White People / Q000235:genetics
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator